Targeted tumor killing via an intracellular antibody against erbB-2. - Wikidata - awgldk - TriplyDB

Targeted tumor killing via an intracellular antibody against erbB-2.

Targeted tumor killing via an intracellular antibody against erbB-2.

http://www.wikidata.org/entity/Q35769154

about

Intrabody and Parkinson's disease Gene therapy for carcinoma of the breast: Genetic ablation strategies Intracellular stability of anti-caspase-3 intrabodies determines efficacy in retargeting the antigen.Intradiabodies, bispecific, tetravalent antibodies for the simultaneous functional knockout of two cell surface receptors.Role of HER2 gene overexpression in breast carcinoma.Phenotypic knockout of VEGF-R2 and Tie-2 with an intradiabody reduces tumor growth and angiogenesis in vivo Molecular and genetic aspects of lung cancer.Persistent expression of biologically active anti-HER2 antibody by AAVrh.10-mediated gene transfer Rapid production of specific vaccines for lymphoma by expression of the tumor-derived single-chain Fv epitopes in tobacco plants Intra-arterial adenoviral mediated tumor transfection in a novel model of cancer gene therapy.Suppression of the c-erbB-2 gene product decreases transformation abilities but not the proliferation and secretion of proteases of SK-OV-3 ovarian cancer cells.Gene therapy of gynaecological diseases.State of the art in tumor antigen and biomarker discovery.State of play and clinical prospects of antibody gene transfer.Establishment and characterization of a new mammary adenocarcinoma cell line derived from MMTV neu transgenic mice.Gene therapy strategies for carcinoma of the breast.HCaRG/COMMD5 inhibits ErbB receptor-driven renal cell carcinoma.A bispecific transmembrane antibody simultaneously targeting intra- and extracellular epitopes of the epidermal growth factor receptor inhibits receptor activation and tumor cell growth.The use of phage display to generate conformation-sensor recombinant antibodies.Adenovirus-mediated ribozyme targeting of HER-2/neu inhibits in vivo growth of breast cancer cells.Intratumoral administration of an adenovirus expressing a kinase dead form of ErbB-2 inhibits tumor growth.Targeted Intracellular Delivery of Antibodies: The State of the Art

P2860

Q24653530-9427B5A0-1617-43AA-BEA2-E722B3586C8C Q24797953-8B02A79A-3CF6-4F50-A997-11F7FC6F4662 Q30683029-FAEF522D-D15A-4C62-8D14-444EA0338264 Q31155271-12F9FCE2-AA0D-47C5-9347-56EBD7335C1E Q33810080-F89C7439-DE83-4769-9E13-ED8FE8473B9E Q33852232-50ABB025-DE6E-466A-89C8-C0ABF03F9913 Q33891465-A7D3937D-7076-4DE7-98C0-A7242EA3B5F2 Q34005560-1B3F5202-ABE6-4D2E-9ED9-24D916A5A403 Q34849268-F6A95F84-3A43-4A4C-8BB9-C825D454DFA9 Q35017991-9383BB1C-AD90-47B4-91B4-B75B60C09727 Q36641004-10CFE78C-24B1-42F3-AE18-90B10D0AE3FE Q36922247-52F5784B-664D-497B-B577-9343482004ED Q37132800-EC8DF6A6-087E-4A0B-805C-17F5E6A15DC2 Q38737706-4B1418BF-8E06-4C97-BDDC-22974CAC3CAC Q41060619-4C4E88EE-832E-444C-80B4-7EF45212B159 Q41540501-3AD4279E-8721-466C-BE76-C6E62D72C1F4 Q42378360-8CC55ACA-8F43-4A5F-8976-02AF87DCC175 Q42628618-8B39750D-EEE6-40F3-B501-67A127AEB95D Q43090031-62F572BA-D979-409D-90EA-D532FC5EC033 Q45865606-3AB0A293-0889-49C7-AFF6-055BD59652A1 Q45887217-CB837331-2EA9-4948-9053-CA0E223DC84D Q58566968-29305B49-02D0-42AB-BD9C-7329E96CDCC3

P2860

Targeted tumor killing via an intracellular antibody against erbB-2.

http://www.wikidata.org/entity/Q35769154

description

1995 nî lūn-bûn

@nan

1995年の論文

@ja

1995年論文

@yue

1995年論文

@zh-hant

1995年論文

@zh-hk

1995年論文

@zh-mo

1995年論文

@zh-tw

1995年论文

@wuu

1995年论文

@zh

1995年论文

@zh-cn

name

Targeted tumor killing via an intracellular antibody against erbB-2.

@ast

Targeted tumor killing via an intracellular antibody against erbB-2.

@en

type

label

Targeted tumor killing via an intracellular antibody against erbB-2.

@ast

Targeted tumor killing via an intracellular antibody against erbB-2.

@en

prefLabel

Targeted tumor killing via an intracellular antibody against erbB-2.

@ast

Targeted tumor killing via an intracellular antibody against erbB-2.

@en

P1433

Q35769154-D1A3F503-099E-4FF1-A15B-DBD160DC9C69

P1476

Q35769154-90D9635D-0146-4C83-B94E-2534F358193C

P2093

Q35769154-0C780CDD-0C20-4688-8906-396320D38BAE

Q35769154-0F803871-6BA9-4DBE-AA08-BAB18F2EF848

Q35769154-1A3347E8-3062-413A-A3DA-CD7C8C57198D

Q35769154-5807C634-DEDD-46FA-8D88-C2AA3E54AD0C

Q35769154-7BC1974A-7B2F-4367-87DC-82F84DCDE9B0

Q35769154-D6AB2B45-D632-4880-9855-3FE5FD1BBF62

Q35769154-EB5A646D-DEE2-414E-A5C4-1B303351C571

Q35769154-F6D6FDAC-DF48-4ECA-AE38-6703FAB8E094

P2860

Q35769154-1B0D7999-25F6-4EFA-869A-2935E033A69D

Q35769154-1B9F97D8-84A3-4838-B70F-310434E02135

Q35769154-1BA47447-9C05-4165-9C86-97A06F02DAB7

Q35769154-2CA5959C-62A6-4352-9FFE-D78564B35A23

Q35769154-3F370235-4308-491A-92BF-448B1A530FFF

Q35769154-4197ACD7-0C00-42AD-AEA2-C8885BA88DBB

Q35769154-44C35F54-02DB-4F63-B6B1-D9B4CDE3C916

Q35769154-48BDCC6C-2C12-4FD5-8C90-289C965DF21B

Q35769154-4C9E0E7B-1E73-470A-A6C0-8D35FB206AFF

Q35769154-5202D911-8E51-4EF1-9A4B-419B2D4CF86B

P304

Q35769154-866645F4-B3DB-4475-AD49-603BD1556D34

P31

Q35769154-9A1098CD-9096-4583-BEA8-49AEC61372BA

P356

Q35769154-EEC7A9CA-9432-4E1E-ACB5-C03D89924C81

P407

Q35769154-BF29338C-BE32-4806-B653-3FBECB8F2813

P433

Q35769154-A9D4C8D7-BEF1-47F5-BC71-5D57FC226D39

P478

Q35769154-5B3340D7-5FF0-4308-8291-444161C9C6EB

P50

Q35769154-EB53CACA-3B56-455C-B006-BE32340DEBBC

P577

Q35769154-D2601644-1E9A-459E-B91E-CBC69659942C

P5875

Q35769154-87F74990-502E-434F-AA20-B787D24899CC

P698

Q35769154-004475A2-039C-4D1F-9281-49977F5855B8

P932

Q35769154-42D95582-667A-424D-AA58-EEC5F82AB903

P356

P1433

Journal of Clinical Investigation

P1476

Targeted tumor killing via an intracellular antibody against erbB-2.

@en

P2093

Alvarez RD

http://www.w3.org/2001/XMLSchema#string

Cabrera G

http://www.w3.org/2001/XMLSchema#string

Deshane J

http://www.w3.org/2001/XMLSchema#string

Feng M

http://www.w3.org/2001/XMLSchema#string

Kay M

http://www.w3.org/2001/XMLSchema#string

Liu T

http://www.w3.org/2001/XMLSchema#string

Siegal GP

http://www.w3.org/2001/XMLSchema#string

Wang MH

http://www.w3.org/2001/XMLSchema#string

P2860

Humanization of an anti-p185HER2 antibody for human cancer therapy

Characterization of murine monoclonal antibodies reactive to either the human epidermal growth factor receptor or HER2/neu gene product

Down-modulation of an oncogene protein product and reversion of the transformed phenotype by monoclonal antibodies

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer

Suppression of human colorectal carcinoma cell growth by wild-type p53

Triplex formation inhibits HER-2/neu transcription in vitro

Increased expression of the putative growth factor receptor p185HER2 causes transformation and tumorigenesis of NIH 3T3 cells.

Suppression and promotion of tumor growth by monoclonal antibodies to ErbB-2 differentially correlate with cellular uptake.

Establishment and characterization of mouse-human chimeric monoclonal antibody to erbB-2 product.

Site-specific oligonucleotide binding represses transcription of the human c-myc gene in vitro.

P304

2980-2989

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1172/JCI118370

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

96

http://www.w3.org/2001/XMLSchema#string

P50

David T. Curiel

P577

1995-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

14525419

http://www.w3.org/2001/XMLSchema#string

P698

8675670

http://www.w3.org/2001/XMLSchema#string

P932

186010

http://www.w3.org/2001/XMLSchema#string